FDA panel recommends Pfizer vaccine for kids 5-11; maker of COVAXIN looks to start US trials of vaccine: COVID-19 updates

FDA panel recommends Pfizer vaccine for kids 5-11; maker of COVAXIN looks to start US trials of vaccine: COVID-19 updates

USATODAY.com

Published

Children are one step closer to being able to receive a COVID-19 vaccine. Ocugen plans to begin US trials of COVAXIN in US. Latest updates.

Full Article